New hope for advanced GI cancer: extra surgery or radiation may extend life
NCT ID NCT07282912
First seen Jan 05, 2026 · Last updated Jun 02, 2026 · Updated 28 times
Summary
This study tests whether adding surgery or radiation to standard chemotherapy helps people with metastatic upper GI cancer live longer without the disease getting worse. It includes 54 adults whose cancer has spread but whose blood shows no detectable tumor DNA after three months of chemo. Participants are randomly assigned to continue standard care alone or add a targeted procedure to remove or treat remaining tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Smilow Cancer Center
RECRUITINGNew Haven, Connecticut, 06519, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.